| 发明名称 |
Treatment of TNFalpha related disorders |
| 摘要 |
<p>Provided is the us of a neutralizing, high affinity human anti-TNFalpha antibody, or antigen binding portion thereof, in the preparation of a medicament for treating psoriatic arthritis, wherein the medicament comprises a dosage of 10-150 mg of the neutralizing, high affinity human anti-TNFalpha antibody, or antigen binding portion thereof.</p> |
| 申请公布号 |
NZ576774(A) |
申请公布日期 |
2011.06.30 |
| 申请号 |
NZ20090576774 |
申请日期 |
2009.05.06 |
| 申请人 |
ABBOTT BIOTECHNOLGY LTD |
发明人 |
BANERJEE, SUBHASHIS;TAYLOR, LORI K;SPIEGLER, CLIVE E;TRACEY, DANIEL EDWARD;CHARTASH, ELLIOT KEITH;HOFFMAN, REBECCA S;BARCHUK, WILLIAM T;YAN, PHILIP;MURTAZA, ANWAR;SALFELD, JOCHEN G;FISCHKOFF, STEVEN |
| 分类号 |
A61K39/395;A61K;C07K;C07K16/00;C07K16/24 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
